References
- MahmoodARNarangATDiagnosis and management of the acute red eyeEmerg Med Clin North Am2008261355518249256
- WirbelauerCManagement of the red eye for the primary care physicianAm J Med2006119430230616564769
- LeibowitzHMThe red eyeN Engl J Med2000343534535110922425
- CronauHKankanalaRMMaugerTDiagnosis and management of red eye in primary careAm Fam Physician201081213714420082509
- EverittHLittlePHow do GPs diagnose and manage acute infective conjunctivitis? A GP surveyFam Pract200219665866012429670
- LeibowitzHMPrattMVFlagstadIJBerrospiARKundsinRHuman conjunctivitis II. TreatmentArch Ophthalmol19769417521756184771
- BarberBLStrahlmanERLaibovitzRGuessHAReinesSAValidation of a questionnaire for comparing the tolerability of ophthalmic medicationsOphthalmology199710423343429052642
- Campoli-RichardsDMChaplinSSayceRHNetilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useDrugs19893857037562689137
- BonfiglioGScuderiACRussoGNetilmicin: in vitro activity, time-kill evaluation and postantibiotic effect on microorganisms isolated from ocular infectionsChemotherapy200147211712211173813
- PapaVAragonaPScuderiACTreatment of acute bacterial conjunctivitis with topical netilmicinCornea2002211434711805506
- BlancoARSudanoRoccaro ASpotoCGPapaVSusceptibility of methicillin-resistant staphylococci clinical isolate sto netilmicin and other antibiotics commonly used in ophthalmic therapyCurr Eye Res [Epub March 27, 2013]
- RussoSPapaVDi BellaADexamethasone–netilmicin: a new ophthalmic steroid–antibiotic combination. Efficacy and safety after cataract surgeryEye (Lond)2007211586416273088
- PianiniVPassaniARossiGCMPassaniFEfficacy and safety of netilmicin/dexamethasone preservative-free and tobramycin/dexamethasone-preserved fixed combination in patients after cataract surgeryJ Ocul Pharmacol Ther201026661762121034176
- CagleGDAbshireRLQuantitative ocular bacteriology: a method for enumeration and identification of bacteria from the skin-lask margin and conjunctivaInvest Ophthalmol Vis Sci19812067517577239845
- JaanusSDCheethamJKLesherGAAnti-inflammatory drugsBartlettJDJaanusSDClinical Ocular Pharmacology4th edWoburn (MA)Butterworth-Heinemann2001265298
- SherifZPleyerUCorticosteroids in ophthalmology: past-present-futureOphthalmologica2002216530531512424394
- PapaVLeonardiAGetuliCPacelliVRussoPMilazzoGEffect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitroJ Ocul Pharmacol Ther200319653554514733711
- MarinoCPaladinoGMScuderiACTrombettaFMugridgeKEneaVIn vivo toxicity of netilmicin and ofloxacin on intact and mechanically damaged eyes of rabbitCornea200524671071616015091
- MilazzoGPapaVCarstoceaBTopical netilmicin compared with tobramycin in the treatment of external ocular infectionInt J Clin Pharmacol Ther199937524324810363623
- WhiteEMMacyJIBatemanKMComstockTLComparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitisCurr Med Res Opin200824128729618062846
- RheeSSMahFSComparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitisAdv Ther2007241606717526462